Home

Opus Genetics, Inc. - Common Stock (IRD)

1.0200
+0.0498 (5.13%)
NASDAQ · Last Trade: Jun 26th, 6:06 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Viatris Eye Drops Data Shows Promise For Blurred Near Visionbenzinga.com
Viatris and Opus Genetics report MR-141 met efficacy and safety goals in Phase 3 VEGA-3 trial for presbyopia, with strong patient-reported benefits.
Via Benzinga · June 26, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 20, 2025
Unusual volume stocks in Tuesday's sessionchartmill.com
Unusual volume stocks are being observed in Tuesday's session.
Via Chartmill · June 3, 2025
Discover the top movers in Friday's pre-market session.chartmill.com
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · March 21, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · March 18, 2025